Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands
Open Access
- 28 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (5) , e1099-e1107
Abstract
The epidemiology of acute bacterial meningitis has changed substantially since the introduction of conjugate vaccines. We analyzed nationwide surveillance data of all cerebrospinal fluid isolates received by the Netherlands Reference Laboratory for Bacterial Meningitis in the Netherlands. We assessed the impact of conjugate vaccines on incidence (defined as episodes per 100 000 population per year) and for different age groups using incidence rate ratios (IRRs), comparing incidence before and after conjugate vaccine introduction. We analyzed 17 393 episodes, of which 5960 episodes (34%) occurred in preschool children (aged 3 months to 4 years). Overall, bacterial meningitis incidence decreased from 6.37 to 1.58 between 1989–1993 and 2014–2019 (IRR, 0.25 [95% confidence interval {CI}, .23–.26]; P < .001). This decrease was most pronounced in preschool and school-aged children (5–15 years); IRR, 0.10 [95% CI, .09–.12] and 0.08 [95% CI, .06–.10]; both P < .001. The incidence was highest in young infants (Streptococcus and Escherichia coli meningitis (42.48 and 19.49, respectively). Conjugate vaccines effectively reduced the incidence of Haemophilus influenzae type b, Neisseria meningitidis serogroup C, and 10 pneumococcal serotypes (IRRs, .02–.04; P < .001). At the end of the observed period, Streptococcus pneumoniae caused the majority of meningitis cases (829/1616 [51%]), mostly in older adults (aged 45–64 years) and elderly adults (aged ≥65 years; incidence of 1.06 and 1.54, respectively). Conjugate vaccines reduced the burden of bacterial meningitis, especially in children. The efforts for new measures to prevent bacterial meningitis should be focused on neonates and elderly, as the residual rate of disease is still high in these age groups.Keywords
Funding Information
- Netherlands Organisation for Health Research and Development (917.17.308)
- Academic Medical Center
This publication has 33 references indexed in Scilit:
- An overview of global GBS epidemiologyVaccine, 2013
- An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the NetherlandsPLOS ONE, 2013
- Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalisPLOS ONE, 2012
- Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine EraClinical and Vaccine Immunology, 2012
- Bacterial Meningitis in the United States, 1998–2007New England Journal of Medicine, 2011
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial MeningitisClinical Microbiology Reviews, 2010
- Community-acquired Haemophilus influenzae meningitis in adultsClinical Microbiology and Infection, 2007
- Analysis of Invasive Haemophilus influenzae Infections after Extensive Vaccination against H. influenzae Type bJournal of Clinical Microbiology, 2004
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Meningococcal Meningitis in Sub-Saharan Africa: A Model for the Epidemic ProcessClinical Infectious Diseases, 1992